DKSH and Pharmanovia partner to provide meds in Southeast Asia

11 July 2022
global-deals-big

Market expansion services provider DKSH has partnered with life cycle management company Pharmanovia, to bring high-quality pharmaceutical products to patients across the Asia Pacific.

Partnering in Laos, Cambodia, Myanmar, Hong Kong, Singapore, Taiwan, Malaysia, and the Philippines, the two companies seek to solidify brand presence, grow market share, and ultimately improve patient health outcomes in Southeast Asia.

DKSH will support Pharmanovia by building dedicated sales and marketing teams on the ground in Asia and manage product distribution in the markets. The firm’s experienced teams and broad distribution network will ensure Pharmanovia’s products reach modern trade, traditional trade, hospitals, clinics, other medical channels, and patients in need across the region.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Biosimilars